Esketamine mitigates endotoxin-induced hippocampal injury by regulating calcium transient and synaptic plasticity via the NF-α1/CREB pathway

被引:1
作者
Xu, Mu [1 ,2 ]
Wang, Jialiang [3 ]
Shi, Jia [1 ,4 ,5 ]
Wu, Xiuyun [1 ]
Zhao, Qin [1 ]
Shen, Hui [3 ]
Chen, Jingli [2 ]
Yu, Jianbo [1 ,4 ,5 ]
机构
[1] Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol & Crit Care Med, Tianjin, Peoples R China
[2] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Dept Anesthesiol, Wuhan 430014, Hubei, Peoples R China
[3] Tianjin Med Univ, Sch Biomed Engn & Technol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China
[4] Inst Integrat Med Acute Abdominal Dis, Tianjin, Peoples R China
[5] Tianjin Key Lab Acute Abdomen Dis Associated Organ, Tianjin, Peoples R China
关键词
Esketamine; Septic encephalopathy; NF-alpha; 1; CREB; Calcium transients; Synaptic plasticity; SEPSIS; DYSFUNCTION; KETAMINE;
D O I
10.1016/j.neuropharm.2025.110362
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Esketamine (ES) has been shown to confer neuroprotection partly by exerting anti-inflammation, alleviating oxidative stress, enhancing neuronal vitality, and promoting synaptic remodeling. Nonetheless, its precise function in SAE and the associated mechanisms are not understood. In this study, we investigated the neuroprotective potential of ES at behavioral, structural, and functional levels in vivo and in vitro. C57BL/6J mice administered with lipopolysaccharide (LPS) served as the research model and were injected with 10 mg/kg ES intraperitoneally. Fiber photometry was performed to record Ca2+ transients during behavioral assays. The neuronal dendritic architecture and synaptic plasticity were examined using the Golgi staining and transmission electron microscopy. Stereotactic administration of siRNA was performed to suppress the NF-alpha 1 expression and determine the role of the NF-alpha 1/CREB pathway in vitro. The neuroprotective effects of ES were verified in primary neurons and HT22 cells using a conditioned culture. The ES treatment alleviated sepsis symptoms, cognitive impairment, and decreased mortality. It also upregulated the NF-alpha 1 expression in the hippocampal CA1 region and reduced neuroinflammation, oxidative stress, and neuronal loss. Moreover, ES treatment normalized the Ca2+ transients and improved dendritic structure as well as synaptic plasticity. However, NF-alpha 1 knockdown p-CREB downregulation abolished the protective effects of ES. This also reversed the phenotypic characteristics of Ca2+ transients, dendritic structure, and post-synaptic plasticity. ES can abolish the LPS-induced hippocampal neurotoxicity in vitro and in vivo models and modulate neuronal Ca2+ transients and post-synaptic plasticity via the NF-alpha 1/CREB signaling pathway. These findings provide a theoretical basis that will guide the future application of ES to treat hippocampal injury in sepsis.
引用
收藏
页数:16
相关论文
共 50 条
[1]   Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairment [J].
Andonegui, Graciela ;
Zelinski, Erin L. ;
Schubert, Courtney L. ;
Knight, Derrice ;
Craig, Laura A. ;
Winston, Brent W. ;
Spanswick, Simon C. ;
Petri, Bjorn ;
Jenne, Craig N. ;
Sutherland, Janice C. ;
Nguyen, Rita ;
Jayawardena, Natalie ;
Kelly, Margaret M. ;
Doig, Christopher J. ;
Sutherland, Robert J. ;
Kubes, Paul .
JCI INSIGHT, 2018, 3 (09)
[2]   CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models [J].
Benito, Eva ;
Barco, Angel .
TRENDS IN NEUROSCIENCES, 2010, 33 (05) :230-240
[3]   Pharmacological and behavioral divergence of ketamine enantiomers:implications for abuse liability [J].
Bonaventura, Jordi ;
Lam, Sherry ;
Carlton, Meghan ;
Boehm, Matthew A. ;
Gomez, Juan L. ;
Solis, Oscar ;
Sanchez-Soto, Marta ;
Morris, Patrick J. ;
Fredriksson, Ida ;
Thomas, Craig J. ;
Sibley, David R. ;
Shaham, Yavin ;
Zarate, Carlos A., Jr. ;
Michaelides, Michael .
MOLECULAR PSYCHIATRY, 2021, 26 (11) :6704-6722
[4]   Silencing of amygdala circuits during sepsis prevents the development of anxiety-related behaviours [J].
Bourhy, Lena ;
Mazeraud, Aurelien ;
Costa, Luis H. A. ;
Levy, Jarod ;
Rei, Damien ;
Hecquet, Esteban ;
Gabanyi, Ilana ;
Bozza, Fernando A. ;
Chretien, Fabrice ;
Lledo, Pierre-Marie ;
Sharshar, Tarek ;
Lepousez, Gabriel .
BRAIN, 2022, 145 (04) :1391-1409
[5]   Upregulation of miR-19b-3p exacerbates chronic stress-induced changes in synaptic plasticity and cognition by targeting Drebrin [J].
Chen, Jingli ;
Liu, Chang ;
Xu, Mu ;
Zhu, Jiaxi ;
Xia, Zhongyuan .
NEUROPHARMACOLOGY, 2022, 207
[6]   Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression A Randomized Clinical Trial [J].
Daly, Ella J. ;
Singh, Jaskaran B. ;
Fedgchin, Maggie ;
Cooper, Kimberly ;
Lim, Pilar ;
Shelton, Richard C. ;
Thase, Michael E. ;
Winokur, Andrew ;
Van Nueten, Luc ;
Manji, Husseini ;
Drevets, Wayne C. .
JAMA PSYCHIATRY, 2018, 75 (02) :139-148
[7]   Carboxypeptidase E conditional knockout mice exhibit learning and memory deficits and neurodegeneration [J].
Fan, Fang-Cheng ;
Du, Yang ;
Zheng, Wen-Hui ;
Loh, Y. Peng ;
Cheng, Yong .
TRANSLATIONAL PSYCHIATRY, 2023, 13 (01)
[8]   Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing [J].
Fanta, Samuel ;
Kinnunen, Mari ;
Backman, Janne T. ;
Kalso, Eija .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (04) :441-447
[9]   Dextran sulfate sodium-induced inflammation and colitis in mice are ameliorated by (R)-ketamine, but not (S)-ketamine: A role of TrkB signaling [J].
Fujita, Yuko ;
Hashimoto, Yaeko ;
Hashimoto, Hiroyo ;
Chang, Lijia ;
Hashimoto, Kenji .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 897
[10]   Targeted rescue of synaptic plasticity improves cognitive decline in sepsis-associated encephalopathy [J].
Gruenewald, Benedikt ;
Wickel, Jonathan ;
Hahn, Nina ;
Rahmati, Vahid ;
Rupp, Hanna ;
Chung, Ha-Yeun ;
Haselmann, Holger ;
Strauss, Anja S. ;
Schmidl, Lars ;
Hempel, Nina ;
Gruenewald, Lena ;
Urbach, Anja ;
Bauer, Michael ;
Toyka, Klaus, V ;
Blaess, Markus ;
Claus, Ralf A. ;
Koenig, Rainer ;
Geis, Christian .
MOLECULAR THERAPY, 2024, 32 (07) :2113-2129